- Home
- BDSX vs LFCR Comparison
BDSX vs LFCR Comparison
Compare BDSX & LFCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDSX
- LFCR
- Stock Information
- Founded
- BDSX 2005
- LFCR 1986
- Country
- BDSX United States
- LFCR United States
- Employees
- BDSX N/A
- LFCR N/A
- Industry
- BDSX Precision Instruments
- LFCR Biotechnology: Pharmaceutical Preparations
- Sector
- BDSX Health Care
- LFCR Health Care
- Exchange
- BDSX Nasdaq
- LFCR Nasdaq
- Market Cap
- BDSX 200.0M
- LFCR 164.3M
- IPO Year
- BDSX 2020
- LFCR N/A
- Fundamental
- Price
- BDSX $1.20
- LFCR $6.98
- Analyst Decision
- BDSX Strong Buy
- LFCR Buy
- Analyst Count
- BDSX 4
- LFCR 2
- Target Price
- BDSX $3.08
- LFCR $8.00
- AVG Volume (30 Days)
- BDSX 732.5K
- LFCR 199.0K
- Earning Date
- BDSX 11-01-2024
- LFCR 10-04-2024
- Dividend Yield
- BDSX N/A
- LFCR N/A
- EPS Growth
- BDSX N/A
- LFCR N/A
- EPS
- BDSX N/A
- LFCR 0.17
- Revenue
- BDSX $65,562,000.00
- LFCR $128,443,999.00
- Revenue This Year
- BDSX $46.97
- LFCR $2.23
- Revenue Next Year
- BDSX $30.43
- LFCR $8.40
- P/E Ratio
- BDSX N/A
- LFCR $41.70
- Revenue Growth
- BDSX 48.92
- LFCR 23.42
- 52 Week Low
- BDSX $1.11
- LFCR $3.68
- 52 Week High
- BDSX $2.21
- LFCR $8.90
- Technical
- Relative Strength Index (RSI)
- BDSX 28.77
- LFCR 61.28
- Support Level
- BDSX $1.11
- LFCR $6.27
- Resistance Level
- BDSX $1.45
- LFCR $7.23
- Average True Range (ATR)
- BDSX 0.09
- LFCR 0.46
- MACD
- BDSX -0.02
- LFCR 0.04
- Stochastic Oscillator
- BDSX 24.32
- LFCR 53.88
About BDSX Biodesix Inc.
Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.
About LFCR Lifecore Biomedical Inc.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that offers differentiated capabilities in the development, filling, and finishing of complex sterile injectable pharmaceutical products in syringes and vials. It manufactures injectable-grade Hyaluronic Acid. Lifecore recognizes revenue in two different product categories, CDMO and fermentation.